Neoadjuvant chemotherapy in locally advanced gastric carcinoma—a phase II trial with combined continuous intravenous 5-fluorouracil and bolus cisplatinum

European Journal of Cancer - Tập 30 - Trang 1269-1275 - 1994
Ph Rougier1, M Mahjoubi1, Ph Lasser1, M Ducreux1, J Oliveira1, M Ychou1, J.P Pignon1, D Elias1, S Bellefqih1, C Bognel1, A Lusinchi1, E Cvitkovic1, J.-P Droz1
1Gastro-Intestinal Unit, Institut Gustave Roussy, 94805 Villejuif Cedex, France

Tài liệu tham khảo

Serlin, 1977, Factors related to survival following resection for gastric carcinoma. Analysis of 903 cases, Cancer, 40, 1318, 10.1002/1097-0142(197709)40:3<1318::AID-CNCR2820400349>3.0.CO;2-9 Allum, 1989, Gastric cancer: a 25-year review, Br J Surg, 76, 535, 10.1002/bjs.1800760604 Weed, 1981, Carcinoma of the stomach: why are we failing to improve survival?, Am Surg, 193, 407 Douglas, 1985, Gastric adenocarcinoma management of the primary disease, Semin Oncol, 12, 32 Dupont, 1978, Adenocarcinoma of the stomach. Review of 1497 cases, Cancer, 41, 941, 10.1002/1097-0142(197803)41:3<941::AID-CNCR2820410323>3.0.CO;2-M McBride, 1987, Adenocarcinoma of the stomach: are we making any progress?, South Med J, 80, 283, 10.1097/00007611-198703000-00002 Gunderson, 1982, Andenocarcinoma of the stomach. Areas of failure in a reoperative serie (second or symptomatic?); clinicopathologic correlation and implication for adjuvant therapy, Int J Radiat Oncol Biol Phys, 8, 1, 10.1016/0360-3016(82)90377-7 Rohde, 1989, Has there been any improvement in the staging of gastric cancer? Findings from the German Gastric Cancer TNM Study Group, Cancer, 64, 2465, 10.1002/1097-0142(19891215)64:12<2465::AID-CNCR2820641212>3.0.CO;2-Y Sue-Ling, 1993, Gastric cancer: a curable disease in Britain, Br Med J, 307, 591, 10.1136/bmj.307.6904.591 Landry, 1986, Patterns of failure following curative resection of gastric carcinoma, Int J Radiat Oncol Biol Phys, 12, 119, 10.1016/0360-3016(86)90557-2 De Calan, 1988, Carcinoma of the cardia and proximal third of the stomach. Results of surgical treatment in 91 consecutive patients, Am J Surg, 155, 481, 10.1016/S0002-9610(88)80118-1 Garnier, 1988, Valeur pronostique des classifications de Lauren et de Ming dans les adenocarcinomes gastriques. Analyse multidimensionnelle, Gastroenterol Clin Biol, 12, 553 1982, Controlled trial of adjuvant chemotherapy following curative resection for gastric cancer, Cancer, 49, 1116, 10.1002/1097-0142(19820315)49:6<1116::AID-CNCR2820490609>3.0.CO;2-U Antoniolli, 1982, Changes in the location and type of gastric adenocarcinoma, Cancer, 50, 775, 10.1002/1097-0142(19820815)50:4<775::AID-CNCR2820500425>3.0.CO;2-W 1982, A comparison of a combination chemotherapy and combined modality therapy for locally advanced gastric carcinoma, Cancer, 49, 1771, 10.1002/1097-0142(19820501)49:9<1771::AID-CNCR2820490907>3.0.CO;2-M Wils, 1989, Current status of chemotherapy for gastric cancer, Eur J Clin Oncol, 25, 3, 10.1016/0277-5379(89)90043-6 Wilke, 1989, Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide doxorubicin and cisplatin, J Clin Oncol, 7, 1318, 10.1200/JCO.1989.7.9.1318 Plukker, 1991, Chemotherapy and surgery for locally advanced cancer of the cardia and fundus: phase II study with methotrexate and 5-fluorouracil, Br J Surg, 78, 955, 10.1002/bjs.1800780820 Lacave, 1987, Cisplatin (CDDP) and 5 fluorouracil (5FU) 120 HR infusion for advanced gastric cancer (GC): a phase II multicenter study, 6, 91 Rougier, 1988, Cisplatin (P) + five days continuous infusion 5FU (C.I. 5FU) in advanced gastric cancer: preliminary results of a phase II trial, 7, 106 Lacave, 1991, Combination chemotherapy with cisplatin and 5-Fluorouracil 5 day infusion in the therapy of advanced gastric cancer: a phase II trial, Ann Oncol, 2, 751, 10.1093/oxfordjournals.annonc.a057858 Watanabe, 1990, Histological Typing of Oesophageal and Gastric Tumours, 19 Santini, 1987, Signet-ring cells in advanced gastric cancer, Acta Path Microbiol Immunol Scand Sect A, 95, 225 Maehara, 1992, Signet ring cell carcinoma of the stomach, Cancer, 69, 1645, 10.1002/1097-0142(19920401)69:7<1645::AID-CNCR2820690702>3.0.CO;2-X Miller, 1981, Reporting results of cancer treatment, Cancer, 47, 214, 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6 Kaplan, 1958, Nonparametric estimation from incomplete observations, J Am Stat Assoc, 53, 457, 10.1080/01621459.1958.10501452 Mantel, 1963, Chi-square tests with one degree of freedom; extension of the Mantel-Haenszel procedure, J Am Stat Assoc, 58, 690 Peto, 1977, Design and analysis of randomised clinical trials requiring prolonged observation of each patient, Br J Cancer, 35, 1, 10.1038/bjc.1977.1 Baba, 1989, Width of serosal invasion and prognosis in advanced human gastric cancer with special reference to the mode of tumor invasion, Cancer, 64, 2482, 10.1002/1097-0142(19891215)64:12<2482::AID-CNCR2820641213>3.0.CO;2-1 Ajani, 1990, Evaluation of pre- and postoperative chemotherapy for resectable adenocarcinoma of the esophagus or gastroesophageal junction, J Clin Oncol, 8, 1231, 10.1200/JCO.1990.8.7.1231 Ajani, 1992, Preoperative and postoperative chemotherapy (CT) for patients with potentially resectable gastric carcinoma, 11, 165 Yonemura, 1993, Neoadjuvant chemotherapy for high-grade advanced gastric cancer, World J Surg, 17, 256, 10.1007/BF01658939 Lerner, 1992, Etoposide, doxorubicin and cisplatin chemotherapy for advanced gastric adenocarcinoma: results of a phase II trial, J Clin Oncol, 10, 536, 10.1200/JCO.1992.10.4.536 Kelsen, 1992, FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment in gastric cancer, J Clin Oncol, 10, 541, 10.1200/JCO.1992.10.4.541 Wils, 1991, Sequential high-dose methotrexate and fluorouracil combined with doxorubicin — a step ahead in the treatment of advanced gastric cancer: a trial of the European Organisation for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group, J Clin Oncol, 9, 827, 10.1200/JCO.1991.9.5.827 O'Connell, 1985, Current status of chemotherapy for advanced pancreatic and gastric cancer, J Clin Oncol, 3, 1032, 10.1200/JCO.1985.3.7.1032 Fisher, 1983, Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases, Cancer Res, 43, 1488 Van Putten, 1985, Optimal timing of adjuvant chemotherapy in mouse models, 15 Moertel, 1968, The natural history of advanced gastric cancer, Surg Gynec Obstet, 126, 1071 Klaassen, 1985, Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5FU alone with radiation plus concurrent and maintenance 5FU. An Eastern Cooperative Oncology Group study, J Clin Oncol, 3, 373, 10.1200/JCO.1985.3.3.373 Bozetti, 1986, A multifactorial approach for the prognosis of patients with carcinoma of the stomach after curative resection, Surg Gynec Obstet, 162, 229 Cook, 1986, Evaluation of gastric adenocarcinoma—abdomina computed tomography does not replace celiotomy, Arch Surg, 121, 603, 10.1001/archsurg.1986.01400050121016 Sussman, 1988, Gastric adenocarcinoma: CT versus surgical staging, Radiology, 167, 335, 10.1148/radiology.167.2.3357941